Go Pro

Octave Specialty Group (OSG) Financials

Octave Specialty Group logo
$6.12 +0.02 (+0.39%)
Closing price 07/17/2026 03:59 PM Eastern
Extended Trading
$6.28 +0.16 (+2.61%)
As of 07/17/2026 05:21 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Octave Specialty Group

Annual Income Statements for Octave Specialty Group

This table shows Octave Specialty Group's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
493 75 -329 186 -216 -437 -17 522 3.63 -556 -259
Consolidated Net Income / (Loss)
986 74 -329 267 -216 -437 -16 -35 -23 -59 -96
Net Income / (Loss) Continuing Operations
1,012 74 -328 268 -247 -334 -17 -50 -27 -72 -111
Total Pre-Tax Income
511 105 -284 273 -183 -440 2.00 -36 -24 -60 -101
Total Revenue
1,146 382 502 157 196 37 95 19 124 155 149
Net Interest Income / (Expense)
150 157 218 -242 -73 -119 -187 0.00 0.00 -9.38 -19
Total Interest Income
266 281 338 0.00 196 103 0.00 0.00 0.00 0.00 0.00
Total Interest Expense
117 124 120 242 269 222 187 0.00 0.00 9.38 19
Long-Term Debt Interest Expense
117 124 120 242 269 222 187 0.00 0.00 9.38 19
Total Non-Interest Income
997 226 284 399 269 156 282 19 124 164 167
Trust Fees by Commissions
- - - - - - - -18 - -41 -37
Other Service Charges
7.15 18 0.00 5.00 134 3.00 27 31 60 103 139
Net Realized & Unrealized Capital Gains on Investments
364 10 109 394 69 94 201 -8.33 13 3.52 -1.56
Premiums Earned
625 197 175 - 66 54 47 14 52 99 67
Total Non-Interest Expense
188 277 786 -116 411 374 94 71 150 225 255
Property & Liability Insurance Claims
-769 - 513 -224 13 225 -88 9.07 37 73 47
Other Operating Expenses
- -11 - -111 - 92 111 56 67 129 192
Amortization Expense
339 175 151 107 295 57 56 5.46 11 24 16
Income Tax Expense
-53 31 44 5.00 32 -3.00 18 -0.46 0.99 0.92 5.21
Other Gains / (Losses), net
- - - - - 0.00 0.00 1.13 - 0.00 0.00
Net Income / (Loss) Attributable to Noncontrolling Interest
- -0.53 0.00 0.00 0.00 0.00 -1.00 0.87 1.32 0.36 2.60
Basic Earnings per Share
$10.92 $1.66 ($7.25) $4.07 ($4.69) ($9.47) ($0.61) $11.48 $0.18 ($11.96) ($5.93)
Weighted Average Basic Shares Outstanding
45.17M 45.22M 45.67M 45.67M 45.95M 46.15M 46.54M 45.72M 45.64M 46.97M 47.18M
Diluted Earnings per Share
$10.72 $1.64 ($7.25) $3.99 ($4.69) ($9.47) ($0.61) $11.48 $0.18 ($11.96) ($5.93)
Weighted Average Diluted Shares Outstanding
45.17M 45.22M 46.56M 46.56M 45.95M 46.15M 46.54M 45.72M 45.64M 46.97M 47.18M
Weighted Average Basic & Diluted Shares Outstanding
45.17M 45.22M 45.37M 45.67M 45.58M 45.85M 46.34M 45.29M 45.20M 46.24M 44.95M

Quarterly Income Statements for Octave Specialty Group

This table shows Octave Specialty Group's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q1 2025 Q2 2025 Q1 2026
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 9/30/2024 3/31/2025 9/30/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders
340 175 -33 -13 66 -16 21 -55 -46 -113 -6.85
Consolidated Net Income / (Loss)
340 -382 -33 -13 66 -43 -3.37 -20 -14 -31 -9.71
Net Income / (Loss) Continuing Operations
340 -397 -37 -18 62 -30 -1.87 -27 -22 -41 -16
Total Pre-Tax Income
342 -387 -29 -11 68 -52 -3.24 -21 -15 -32 -3.34
Total Revenue
26 -113 29 35 45 16 41 66 39 39 209
Net Interest Income / (Expense)
-49 138 -16 -16 -16 48 3.67 -0.20 -5.45 -6.19 0.27
Total Interest Income
0.00 - 0.00 0.00 0.00 - 3.67 3.54 0.00 0.00 2.36
Investment Securities Interest Income
- - - - - - 3.67 3.54 - - 2.36
Total Interest Expense
49 -138 16 16 16 -48 0.00 3.75 5.45 6.19 2.09
Long-Term Debt Interest Expense
49 -138 16 16 16 -48 0.00 3.75 5.45 6.19 2.09
Total Non-Interest Income
75 -251 45 51 61 -32 37 67 45 45 208
Other Service Charges
7.00 9.27 14 10 15 21 18 39 37 36 82
Net Realized & Unrealized Capital Gains on Investments
61 -229 25 32 36 -80 3.59 0.02 2.81 3.17 2.36
Premiums Earned
11 -26 14 15 18 4.91 26 27 16 17 20
Other Non-Interest Income
- - - - - - - - - - 104
Total Non-Interest Expense
-315 288 62 51 -18 54 42 94 62 81 225
Salaries and Employee Benefits
- - - - - - - 9.50 - - 14
Property & Liability Insurance Claims
-353 350 18 7.00 -76 88 19 20 10 14 20
Current and Future Benefits
- - - - - - - - - - 108
Other Operating Expenses
31 -34 36 36 49 -54 18 44 39 54 53
Depreciation Expense
- - - - - - - 7.79 - - 13
Amortization Expense
7.00 -29 8.00 8.00 9.00 -10 5.56 12 13 13 18
Income Tax Expense
2.00 -3.46 4.00 2.00 1.00 -7.99 0.13 -0.87 -0.62 -1.24 -0.48
Net Income / (Loss) Discontinued Operations
- - - - - - - -9.39 - - 0.00
Net Income / (Loss) Attributable to Noncontrolling Interest
0.00 0.87 -1.00 0.00 0.00 2.32 -0.70 -28 -46 -113 -9.71
Other Adjustment to Net Income / (Loss) Attributable to Common Shareholders)
- - - - - - - - - - 0.00
Basic Earnings per Share
$7.50 $3.83 ($0.73) ($0.29) $1.44 ($0.24) $0.44 ($0.63) ($1.21) ($2.35) ($0.26)
Weighted Average Basic Shares Outstanding
45.31M 45.72M 45.56M 45.76M 45.64M 45.64M 45.83M 47.69M 47.31M 48.11M 45.30M
Diluted Earnings per Share
$7.41 $3.92 ($0.73) ($0.29) $1.41 ($0.21) $0.44 ($0.63) ($1.21) ($2.35) ($0.26)
Weighted Average Diluted Shares Outstanding
45.85M 45.72M 45.56M 45.76M 46.81M 45.64M 45.83M 47.69M 47.31M 48.11M 45.30M
Weighted Average Basic & Diluted Shares Outstanding
44.97M 45.29M 45.32M 45.30M 45.19M 45.20M 47.44M - 46.43M 43.81M 45.01M

Annual Cash Flow Statements for Octave Specialty Group

This table details how cash moves in and out of Octave Specialty Group's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
0.00 54 529 -541 -2.00 -46 263 -33 -7.74 -239 -162
Net Cash From Operating Activities
0.00 830 -221 -1,543 -311 -175 -131 0.00 3.72 19 39
Net Cash From Continuing Operating Activities
0.00 -803 -1,023 1,910 415 110 144 0.00 3.72 19 39
Net Income / (Loss) Continuing Operations
0.00 149 -329 453 -216 -437 -33 0.00 0.00 0.00 0.00
Depreciation Expense
- 1.22 1.00 1.00 0.00 1.00 2.00 - 5.23 20 42
Non-Cash Adjustments to Reconcile Net Income
- 76 -5.00 -102 -107 421 -33 - -1.51 -0.63 -2.46
Net Cash From Investing Activities
0.00 -453 1,163 1,588 1,000 432 776 -18 -6.95 -244 -218
Net Cash From Continuing Investing Activities
0.00 -453 1,165 1,589 999 581 776 -18 -6.95 -244 -218
Acquisitions
- - - 0.00 0.00 74 - -18 -6.95 -244 -218
Net Cash From Financing Activities
0.00 -319 -412 -585 -691 -303 -657 -14 -4.51 -15 16
Net Cash From Continuing Financing Activities
0.00 -319 -410 -585 -711 -302 -656 -14 -4.51 -15 16
Issuance of Debt
- - 0.00 264 12 0.00 1,174 - 0.00 0.00 117
Repurchase of Common Equity
- -2.72 0.00 0.00 - 0.00 0.00 -14 -4.51 -12 -30
Other Financing Activities, Net
- -279 -261 -435 -545 -181 -177 - 0.00 -2.97 -71

Quarterly Cash Flow Statements for Octave Specialty Group

This table details how cash moves in and out of Octave Specialty Group's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q1 2025 Q2 2025 Q1 2026
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 3/31/2025 6/30/2025 3/31/2026
Net Change in Cash & Equivalents
-249 42 254 -296 283 393 26 16 57 -38 7.93
Net Cash From Operating Activities
48 -59 0.00 - 112 97 26 16 0.00 -42 7.55
Net Cash From Continuing Operating Activities
26 -64 0.00 - 1.00 36 26 16 -13 -42 7.55
Net Income / (Loss) Continuing Operations
-8.00 - 0.00 - 40 -6.87 24 14 -61 -52 0.00
Net Income / (Loss) Discontinued Operations
- - - - - - 24 14 - -52 0.00
Depreciation Expense
- - - - - 0.08 1.61 1.61 9.18 9.74 12
Changes in Operating Assets and Liabilities, net
17 - - - - 65 - - 20 - -4.66
Net Cash From Investing Activities
-5.00 -453 254 -296 563 -86 0.00 - 34 - 0.00
Net Cash From Continuing Investing Activities
-171 -287 254 -296 575 -560 0.00 - 21 - 0.00
Acquisitions
- -18 0.00 - - - 0.00 - - - 0.00
Net Cash From Financing Activities
-45 465 0.00 - -392 381 0.00 - -2.31 4.04 0.38
Net Cash From Continuing Financing Activities
-105 394 0.00 - -393 -30 0.00 - -54 4.04 0.38
Other Financing Activities, Net
-47 - - - - 285 - - -2.31 - 0.38
Cash Interest Paid
- - - - - - - - 3.82 - 0.00
Cash Income Taxes Paid
- - - - - - - - 1.89 - 1.48

Annual Balance Sheets for Octave Specialty Group

This table presents Octave Specialty Group's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
23,728 - 23,192 14,589 0.00 13,220 12,303 7,973 8,428 8,058 2,223
Cash and Due from Banks
36 - 624 63 - 20 - - - - 68
Restricted Cash
5.82 - 0.98 19 - 13 5.00 58 31 47 41
Trading Account Securities
7,782 - 15,863 9,849 - 6,536 5,915 1,481 136 157 1,003
Loans and Leases, Net of Allowance
0.00 - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Unearned Premiums Asset
928 - 639 556 - 440 413 508 321 512 221
Deferred Acquisition Cost
- - - - - - 0.00 3.00 11 8.57 9.73
Goodwill
0.00 - - - - 46 46 61 70 418 540
Intangible Assets
1,212 - 847 719 - 409 362 326 61 345 475
Other Assets
13,739 - -3,004 7,250 - 6,342 6,077 3,528 7,811 6,571 622
Total Liabilities & Shareholders' Equity
23,728 - 23,192 14,589 0.00 13,220 12,303 7,973 8,428 8,058 2,223
Total Liabilities
21,770 - 21,547 18,931 0.00 12,074 11,187 6,647 6,997 6,863 1,137
Short-Term Debt
2,282 - - 77 - - - - 0.00 150 0.00
Accrued Interest Payable
359 - 437 376 - 517 576 427 0.00 2.56 1.34
Long-Term Debt
13,553 - 992 2,929 - 7,063 6,286 3,427 0.00 0.00 118
Claims and Claim Expense
4,088 - - 1,826 - 1,759 1,570 805 197 349 460
Unearned Premiums Liability
1,280 - 783 630 - 456 395 372 155 182 187
Other Long-Term Liabilities
208 - 224 13,093 - 296 261 293 6,653 6,179 364
Redeemable Noncontrolling Interest
- - - - 0.00 7.00 18 20 17 199 253
Total Equity & Noncontrolling Interests
1,958 - 1,645 1,633 0.00 1,140 1,098 1,305 1,415 996 833
Total Preferred & Common Equity
1,685 - 1,381 1,592 0.00 1,080 1,038 1,252 1,362 798 716
Preferred Stock
0.00 - 0.00 0.00 - 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
1,685 - 1,381 1,592 0.00 1,079 1,038 1,253 1,362 798 716
Common Stock
191 - 200 219 - 242 257 274 292 331 370
Retained Earnings
1,478 - 1,234 1,421 - 759 726 1,245 1,246 684 370
Treasury Stock
-0.12 - -0.47 0.00 - -1.00 -3.00 -13 -17 -28 -33
Accumulated Other Comprehensive Income / (Loss)
15 - -52 -49 - 79 58 -253 -160 -188 8.48
Noncontrolling Interest
274 - 264 41 - 60 60 53 53 198 117

Quarterly Balance Sheets for Octave Specialty Group

This table presents Octave Specialty Group's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q1 2025 Q2 2025 Q1 2026
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 9/30/2024 3/31/2025 9/30/2025 3/31/2026
Total Assets
9,412 8,219 8,132 11,823 13,518 8,253 2,148 2,267
Cash and Due from Banks
29 - - 348 187 - 104 94
Restricted Cash
6.00 314 319 269 63 - 24 47
Trading Account Securities
8,207 1,954 1,979 9,618 10,132 628 1,633 830
Loans and Leases, Net of Allowance
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Unearned Premiums Asset
361 402 469 483 584 209 236 233
Deferred Acquisition Cost
- 4.00 4.00 8.00 13 9.62 9.28 16
Goodwill
46 61 61 70 434 429 445 533
Intangible Assets
318 321 317 312 598 345 339 458
Other Assets
4,355 2,467 2,381 2,004 2,432 6,566 619 685
Total Liabilities & Shareholders' Equity
9,412 8,219 8,132 7,847 9,256 8,253 2,148 2,267
Total Liabilities
8,324 6,892 6,809 10,499 11,654 7,042 1,000 1,237
Short-Term Debt
- - - - 148 150 0.00 0.00
Accrued Interest Payable
576 438 450 462 515 2.70 0.00 1.31
Long-Term Debt
2,201 497 501 3,204 3,514 0.00 0.00 117
Claims and Claim Expense
1,009 851 863 850 1,261 373 438 487
Unearned Premiums Liability
359 389 394 407 458 181 197 199
Other Long-Term Liabilities
317 -59 23 1,324 1,795 6,320 358 427
Redeemable Noncontrolling Interest
36 20 20 22 204 185 188 196
Total Equity & Noncontrolling Interests
1,071 1,307 1,303 1,318 1,670 1,026 959 834
Total Preferred & Common Equity
1,009 1,254 1,250 1,265 1,465 852 843 713
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
1,008 1,254 1,251 1,264 1,465 852 843 713
Common Stock
270 278 283 286 328 334 368 381
Retained Earnings
1,068 1,206 1,191 1,257 1,235 681 492 364
Treasury Stock
-15 -13 -14 -17 -17 -30 -28 -33
Accumulated Other Comprehensive Income / (Loss)
-315 -217 -209 -262 -81 -133 12 1.22
Noncontrolling Interest
62 53 53 53 205 174 116 121

Annual Metrics And Ratios for Octave Specialty Group

This table displays calculated financial ratios and metrics derived from Octave Specialty Group's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
45,020,521.00 45,121,788.00 45,251,166.00 45,336,278.00 45,553,840.00 45,809,139.00 - - - - 43,812,035.00
DEI Adjusted Shares Outstanding
45,020,521.00 45,121,788.00 45,251,166.00 45,336,278.00 45,553,840.00 45,809,139.00 - - - - 43,812,035.00
DEI Earnings Per Adjusted Shares Outstanding
21.90 1.65 -7.27 5.89 -4.74 -9.54 - - - - -2.19
Growth Metrics
- - - - - - - - - - -
Revenue Growth
1,500.07% -66.64% 31.27% -68.73% 24.84% -81.12% 156.76% -79.83% 550.88% 270.15% -3.99%
EBITDA Growth
778.94% -66.80% -173.10% 177.46% -93.03% -1,829.41% 115.31% -202.63% 58.94% -303.81% -26.25%
EBIT Growth
1,242.16% -89.05% -370.41% 196.13% -178.75% -56.74% 100.30% -5,263.90% 53.13% -396.60% -49.97%
NOPAT Growth
689.80% -86.83% -367.50% 234.81% -147.80% -140.44% 94.81% -56.21% 32.17% -147.08% -68.79%
Net Income Growth
1,280.33% -92.46% -542.70% 181.16% -180.90% -102.31% 96.34% -120.28% 34.08% -2,547.25% -62.60%
EPS Growth
0.00% -84.70% -542.07% 155.03% -217.54% -101.92% 93.56% 1,981.97% -98.43% -6,122.22% 50.42%
Operating Cash Flow Growth
100.00% 0.00% -126.62% -598.19% 79.84% 43.73% 25.14% 100.00% 0.00% -100.00% 104.45%
Free Cash Flow Firm Growth
0.00% 203.71% -115.87% 249.55% -134.52% -481.72% 109.29% 231.73% 25.93% -98.66% 60.54%
Invested Capital Growth
0.00% -100.00% 0.00% -150.66% 100.00% 0.00% -9.83% -35.79% -69.88% -6.02% -10.54%
Revenue Q/Q Growth
0.00% -58.81% 0.00% 0.00% 189.60% 0.00% 0.00% -81.02% -60.27% 0.00% 0.00%
EBITDA Q/Q Growth
0.00% -63.63% 0.00% 0.00% 118.73% 0.00% 0.00% -115.45% -107.77% 0.00% 0.00%
EBIT Q/Q Growth
0.00% -91.14% 0.00% 0.00% 33.62% 0.00% 0.00% -117.21% -112.81% 0.00% 0.00%
NOPAT Q/Q Growth
0.00% 110.92% 0.00% 0.00% -95.37% 0.00% 0.00% -107.51% -108.65% 0.00% 0.00%
Net Income Q/Q Growth
0.00% -92.67% 0.00% 0.00% -71.62% 0.00% 0.00% -111.15% -111.91% 0.00% 0.00%
EPS Q/Q Growth
0.00% 0.00% 0.00% 0.00% -64.56% 0.00% 0.00% 0.00% -95.65% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
100.00% 11.68% 0.00% 0.00% 26.14% 3.85% 9.03% -100.00% -84.91% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth
0.00% 184.98% -113.94% 0.00% 66.91% 0.00% 0.00% 0.00% 416.81% 0.00% 0.00%
Invested Capital Q/Q Growth
0.00% -100.00% 0.00% 0.00% -100.00% 0.00% 0.00% 44.51% -68.38% 0.00% 0.00%
Profitability Metrics
- - - - - - - - - - -
EBITDA Margin
113.21% 112.68% -62.75% 155.41% 8.67% -794.59% 47.37% -240.96% -15.20% -16.58% -43.11%
EBIT Margin
83.63% 27.46% -56.57% 173.89% -109.69% -910.81% 1.05% -269.43% -19.40% -26.03% -71.34%
Profit (Net Income) Margin
86.01% 19.43% -65.54% 170.06% -110.20% -1,181.08% -16.84% -183.89% -18.62% -133.19% -64.47%
Tax Burden Percent
193.06% 70.76% 115.85% 97.80% 118.03% 99.32% -800.00% 98.71% 95.92% 1,027.67% 94.84%
Interest Burden Percent
53.27% 100.00% 100.00% 100.00% 85.12% 130.56% 200.00% 69.15% 100.08% 49.79% 95.29%
Effective Tax Rate
-10.46% 29.24% 0.00% 1.83% 0.00% 0.00% 900.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
6.34% 0.84% -15.08% 41.20% 0.00% -7.50% -0.21% -0.41% -0.55% -3.02% -5.55%
ROIC Less NNEP Spread (ROIC-NNEP)
11.67% 0.84% -41.34% 41.30% 0.00% -11.16% -0.21% -0.62% -0.91% -767.17% -24.30%
Return on Net Nonoperating Assets (RNNOA)
94.37% 6.75% -24.92% -24.91% 0.00% -68.69% -1.21% -2.48% -1.14% -43.80% -2.85%
Return on Equity (ROE)
100.71% 7.59% -39.99% 16.29% -26.45% -76.20% -1.41% -2.89% -1.69% -46.82% -8.40%
Cash Return on Invested Capital (CROIC)
-193.66% 200.84% -215.08% 0.00% 0.00% -207.50% 10.13% 43.18% 106.86% 3.19% 5.58%
Operating Return on Assets (OROA)
8.08% 0.89% -2.45% 1.45% -2.95% -5.10% 0.01% -0.51% -0.30% -1.46% -2.06%
Return on Assets (ROA)
8.31% 0.63% -2.84% 1.41% -2.96% -6.61% -0.13% -0.35% -0.28% -7.46% -1.86%
Return on Common Equity (ROCE)
86.64% 6.53% -33.57% 14.77% -25.79% -71.68% -1.32% -2.71% -1.60% -39.54% -5.57%
Return on Equity Simple (ROE_SIMPLE)
58.53% 0.00% -23.82% 16.77% 0.00% -40.46% -1.54% -2.82% -1.71% -71.77% -13.38%
Net Operating Profit after Tax (NOPAT)
564 74 -199 268 -128 -308 -16 -25 -17 -42 -71
NOPAT Margin
49.22% 19.43% -39.60% 170.70% -65.36% -832.43% -16.84% -130.41% -13.59% -9.07% -47.58%
Net Nonoperating Expense Percent (NNEP)
-5.33% 0.00% 26.26% -0.10% -5.92% 3.65% 0.00% 0.21% 0.37% 764.16% 18.76%
SG&A Expenses to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 15.79% 0.00% 23.62% 8.85% 0.00%
Operating Expenses to Revenue
16.37% 72.54% 156.57% -73.89% 209.69% 1,010.81% 98.95% 369.43% 119.40% 126.03% 171.34%
Earnings before Interest and Taxes (EBIT)
959 105 -284 273 -215 -337 1.00 -52 -24 -120 -106
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
1,298 431 -315 244 17 -294 45 -46 -19 -77 -64
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.38 0.00 0.52 0.49 0.00 0.65 0.72 0.63 0.55 0.70 0.48
Price to Tangible Book Value (P/TBV)
1.34 0.00 1.35 0.90 0.00 1.13 1.18 0.91 0.61 6.39 0.00
Price to Revenue (P/Rev)
0.55 2.65 1.44 4.98 5.01 19.04 7.82 40.92 5.97 1.30 2.29
Price to Earnings (P/E)
1.29 13.56 0.00 4.20 0.00 0.00 0.00 1.50 205.07 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
77.78% 7.37% 0.00% 23.80% 0.00% 0.00% 0.00% 66.57% 0.49% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.94 0.00 0.51 0.00 0.00 0.95 0.96 0.89 0.55 0.76 0.60
Enterprise Value to Revenue (EV/Rev)
14.57 2.65 2.70 23.86 5.01 210.85 74.76 220.51 6.28 2.22 4.84
Enterprise Value to EBITDA (EV/EBITDA)
12.87 2.36 0.00 15.35 57.80 0.00 157.83 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
17.42 9.67 0.00 13.72 0.00 0.00 7,102.18 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
29.60 13.66 0.00 13.98 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 1.22 0.00 0.00 0.00 0.00 0.00 0.00 3.74 0.00 18.22
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.06 0.00 0.88 0.00 0.00 8.98 1.61 0.24 23.12 10.12
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
8.09 0.00 0.60 1.84 0.00 6.16 5.63 2.59 0.00 0.13 0.11
Long-Term Debt to Equity
6.92 0.00 0.60 1.79 0.00 6.16 5.63 2.59 0.00 0.00 0.11
Financial Leverage
8.09 8.09 0.60 -0.60 -1.82 6.16 5.90 3.98 1.24 0.06 0.12
Leverage Ratio
12.12 12.12 14.10 11.52 8.93 11.53 11.28 8.31 5.95 6.28 4.51
Compound Leverage Factor
6.45 12.12 14.10 11.52 7.60 15.05 22.56 5.74 5.95 3.12 4.29
Debt to Total Capital
88.99% 0.00% 37.61% 64.80% 0.00% 86.03% 84.92% 72.12% 0.00% 11.15% 9.77%
Short-Term Debt to Total Capital
12.82% 0.00% 0.00% 1.66% 0.00% 0.00% 0.00% 0.00% 0.00% 11.15% 0.00%
Long-Term Debt to Total Capital
76.17% 0.00% 37.61% 63.14% 0.00% 86.03% 84.92% 72.12% 0.00% 0.00% 9.77%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
1.54% 0.00% 10.02% 0.88% 0.00% 0.82% 1.05% 1.54% 4.89% 25.17% 30.77%
Common Equity to Total Capital
9.47% 0.00% 52.38% 34.32% 0.00% 13.14% 14.02% 26.36% 95.11% 63.69% 59.46%
Debt to EBITDA
12.20 0.00 -3.15 12.32 0.00 -24.02 139.69 -74.20 0.00 -1.96 -1.84
Net Debt to EBITDA
12.17 0.00 -1.17 11.98 0.00 -23.91 139.58 -72.95 0.00 -1.11 -0.13
Long-Term Debt to EBITDA
10.44 0.00 -3.15 12.00 0.00 -24.02 139.69 -74.20 0.00 0.00 -1.84
Debt to NOPAT
28.07 0.00 -4.99 11.22 0.00 -22.93 -392.88 -137.11 0.00 -3.58 -1.66
Net Debt to NOPAT
27.99 0.00 -1.85 10.91 0.00 -22.82 -392.56 -134.79 0.00 -2.03 -0.12
Long-Term Debt to NOPAT
24.02 0.00 -4.99 10.93 0.00 -22.93 -392.88 -137.11 0.00 0.00 -1.66
Noncontrolling Interest Sharing Ratio
13.97% 13.97% 16.05% 9.31% 2.51% 5.93% 6.45% 6.16% 5.16% 15.55% 33.64%
Liquidity Ratios
- - - - - - - - - - -
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-17,229 17,868 -2,836 4,241 -1,464 -8,517 791 2,624 3,304 44 71
Operating Cash Flow to CapEx
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense
-147.84 143.70 -23.63 17.52 -5.44 -38.36 4.23 0.00 0.00 4.72 3.81
Operating Cash Flow to Interest Expense
0.00 6.68 -1.84 -6.38 -1.16 -0.79 -0.70 0.00 0.00 0.00 2.12
Operating Cash Flow Less CapEx to Interest Expense
0.00 6.68 -1.84 -6.38 -1.16 -0.79 -0.70 0.00 0.00 0.00 2.12
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.10 0.03 0.04 0.01 0.03 0.01 0.01 0.00 0.02 0.06 0.03
Fixed Asset Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
17,793 0.00 2,637 -1,336 0.00 8,209 7,402 4,753 1,432 1,346 1,204
Invested Capital Turnover
0.13 0.04 0.38 0.24 -0.29 0.01 0.01 0.00 0.04 0.33 0.12
Increase / (Decrease) in Invested Capital
17,793 -17,793 2,637 -3,973 1,336 8,209 -807 -2,649 -3,321 -86 -142
Enterprise Value (EV)
16,701 1,015 1,354 3,747 983 7,802 7,102 4,226 784 1,024 720
Market Capitalization
634 1,015 723 782 983 705 743 784 745 600 341
Book Value per Share
$37.42 $0.00 $30.52 $35.12 $0.00 $23.55 $22.42 $27.86 $30.13 $18.06 $16.34
Tangible Book Value per Share
$10.50 $0.00 $11.80 $19.26 $0.00 $13.62 $13.61 $19.25 $27.23 $1.98 ($6.84)
Total Capital
17,793 0.00 2,637 4,639 0.00 8,210 7,402 4,752 1,432 1,346 1,204
Total Debt
15,835 0.00 992 3,006 0.00 7,063 6,286 3,427 0.00 150 118
Total Long-Term Debt
13,553 0.00 992 2,929 0.00 7,063 6,286 3,427 0.00 0.00 118
Net Debt
15,793 0.00 367 2,924 0.00 7,030 6,281 3,369 -31 85 8.36
Capital Expenditures (CapEx)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Nonoperating Expense (NNE)
-422 0.00 130 1.00 88 129 0.00 10 6.28 573 25
Net Nonoperating Obligations (NNO)
15,835 0.00 992 -2,969 0.00 7,062 6,286 3,428 0.00 150 118
Total Depreciation and Amortization (D&A)
339 326 -31 -29 232 43 44 5.46 5.24 44 42
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $1.66 $0.00 $4.07 ($4.69) ($9.47) ($0.61) $11.48 $0.18 ($10.84) ($5.93)
Adjusted Weighted Average Basic Shares Outstanding
45.05M 45.22M 45.12M 45.34M 0.00 46.15M 46.54M 45.72M 45.64M 46.97M 47.18M
Adjusted Diluted Earnings per Share
$0.00 $1.64 $0.00 $3.99 ($4.69) ($9.47) ($0.61) $11.31 $0.18 ($10.84) ($5.93)
Adjusted Weighted Average Diluted Shares Outstanding
45.05M 45.22M 45.12M 45.34M 0.00 46.15M 46.54M 46.41M 46.54M 46.97M 47.18M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 ($4.69) $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
45.05M 45.22M 45.12M 45.34M 45.58M 45.85M 46.34M 45.29M 45.20M 46.24M 44.95M
Normalized Net Operating Profit after Tax (NOPAT)
718 74 -199 268 -128 -308 1.40 -25 -17 -42 -71
Normalized NOPAT Margin
62.60% 19.43% -39.60% 170.70% -65.36% -832.43% 1.47% -130.41% -13.59% -9.07% -47.58%
Pre Tax Income Margin
44.55% 27.46% -56.57% 173.89% -93.37% -1,189.19% 2.11% -186.30% -19.42% -12.96% -67.98%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
8.23 0.84 -2.37 1.13 -0.80 -1.52 0.01 0.00 0.00 -12.81 -5.69
NOPAT to Interest Expense
4.84 0.60 -1.66 1.11 -0.48 -1.39 -0.09 0.00 0.00 -4.47 -3.79
EBIT Less CapEx to Interest Expense
8.23 0.84 -2.37 1.13 -0.80 -1.52 0.01 0.00 0.00 -12.81 -5.69
NOPAT Less CapEx to Interest Expense
4.84 0.60 -1.66 1.11 -0.48 -1.39 -0.09 0.00 0.00 -4.47 -3.79
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 3.66% 0.00% 0.00% 0.00% 0.00% 0.00% -40.34% -19.41% -1.90% -31.25%

Quarterly Metrics And Ratios for Octave Specialty Group

This table displays calculated financial ratios and metrics derived from Octave Specialty Group's official financial filings.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q1 2025 Q2 2025 Q1 2026
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 9/30/2024 9/30/2024 3/31/2025 9/30/2025 3/31/2026
DEI Shares Outstanding
- - - - - - - 47,440,995.00 46,427,421.00 46,401,736.00 44,951,913.00
DEI Adjusted Shares Outstanding
- - - - - - - 47,440,995.00 46,427,421.00 46,401,736.00 44,951,913.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - -0.42 -0.31 -0.66 -0.22
Growth Metrics
- - - - - - - - - - -
Revenue Growth
0.00% -263.98% -57.97% -5.41% 73.08% 113.96% 231.03% 89.54% -3.21% -41.35% 428.90%
EBITDA Growth
814.71% -946.79% -292.31% -144.44% -76.85% 89.52% 112.00% -227.10% -3,169.23% -23.09% -1.88%
EBIT Growth
1,211.54% -717.63% -1,750.00% -366.67% -81.52% 90.46% 51.52% -73.64% -1,172.31% -51.00% 25.44%
NOPAT Growth
1,689.47% -2,048.37% -776.67% -254.00% -80.29% 86.50% 6.90% -88.70% -366.41% -54.55% 77.86%
Net Income Growth
1,207.69% -1,133.05% -1,750.00% -360.00% -80.59% 88.69% 12.12% -53.00% -330.10% -55.04% 32.96%
EPS Growth
0.00% 0.00% -1,925.00% -363.64% -80.97% -105.36% 13.70% -117.24% -375.00% -273.02% 78.51%
Operating Cash Flow Growth
190.57% -1,280.00% -100.00% 0.00% 133.33% 265.10% 0.00% 0.00% -100.00% -368.49% 0.00%
Free Cash Flow Firm Growth
-174.18% 0.00% 142.99% 140.05% 60.28% 38.11% -367.56% 48.28% 212.14% -164.65% -94.88%
Invested Capital Growth
164,550.00% -35.79% -43.62% -40.24% 37.67% -69.88% 202.96% 0.00% -75.36% 0.00% -15.78%
Revenue Q/Q Growth
-29.73% -533.98% -85.85% 20.69% 28.57% -65.01% 509.64% 62.80% 0.00% -2.41% 0.00%
EBITDA Q/Q Growth
1,627.78% -238.00% -111.42% 68.00% 1,000.00% -162.45% 106.67% -20,029.23% 0.00% -155.93% 0.00%
EBIT Q/Q Growth
5,583.33% -217.49% -118.86% 51.52% 493.75% -160.64% 58.12% -1,493.00% 0.00% -92.78% 0.00%
NOPAT Q/Q Growth
6,700.00% -179.62% -111.60% 62.07% 970.13% -154.56% 48.30% -540.85% 0.00% -112.35% 0.00%
Net Income Q/Q Growth
6,700.00% -212.42% -118.86% 60.61% 607.69% -165.50% 32.92% -490.38% 0.00% -112.82% 0.00%
EPS Q/Q Growth
6,636.36% -47.10% -119.47% 60.27% 586.21% -114.89% -200.00% -243.18% 0.00% -92.62% 0.00%
Operating Cash Flow Q/Q Growth
2,300.00% -222.92% -100.00% 0.00% 0.00% -13.03% -100.00% -38.67% 0.00% -101.27% 0.00%
Free Cash Flow Firm Q/Q Growth
3.15% 180.59% -50.75% -12.25% -196.04% 380.27% -213.28% 148.85% 0.00% -128.16% 0.00%
Invested Capital Q/Q Growth
7.77% 44.51% -61.62% 0.00% 148.25% -68.38% 285.98% -100.00% 0.00% -15.72% 0.00%
Profitability Metrics
- - - - - - - - - - -
EBITDA Margin
1,196.15% 0.00% -86.21% -22.86% 160.00% -285.53% 3.13% -39.45% -10.78% -82.79% -2.08%
EBIT Margin
1,311.54% 0.00% -113.79% -45.71% 140.00% -242.60% -16.67% -41.88% -56.26% -107.83% -7.93%
Profit (Net Income) Margin
1,307.69% 0.00% -113.79% -37.14% 146.67% -274.54% -30.21% -29.98% -36.74% -79.26% -4.66%
Tax Burden Percent
99.42% 98.85% 113.79% 118.18% 97.06% 82.79% 107.41% 95.82% 95.92% 96.13% 290.49%
Interest Burden Percent
100.29% 96.52% 87.88% 68.75% 107.94% 136.70% 168.75% 74.71% 68.08% 76.47% 20.21%
Effective Tax Rate
0.58% 0.00% 0.00% 0.00% 1.47% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
80.36% 0.00% -8.22% -2.66% 0.00% -9.36% -1.03% 0.00% -1.19% -43.60% -0.28%
ROIC Less NNEP Spread (ROIC-NNEP)
80.36% 0.00% -9.14% -3.06% 0.00% -9.75% -1.51% 0.00% -1.40% 0.00% -5.81%
Return on Net Nonoperating Assets (RNNOA)
158.26% 0.00% -10.96% -3.71% 0.00% -12.13% -1.96% 0.00% -1.73% 0.00% -0.69%
Return on Equity (ROE)
238.62% 0.00% -19.17% -6.37% -29.61% -21.49% -2.99% 0.00% -2.92% 0.00% -0.98%
Cash Return on Invested Capital (CROIC)
0.00% 43.18% 75.03% 69.61% -38.12% 106.86% -101.16% 0.00% 119.47% -210.13% 12.15%
Operating Return on Assets (OROA)
28.15% 0.00% -3.42% -1.48% 0.00% -3.69% -0.29% 0.00% -0.79% -21.76% -0.48%
Return on Assets (ROA)
28.07% 0.00% -3.42% -1.20% 0.00% -4.18% -0.53% 0.00% -0.52% -15.99% -0.28%
Return on Common Equity (ROCE)
217.28% 0.00% -18.06% -5.87% -27.49% -20.38% -2.54% 0.00% -2.19% 0.00% -0.68%
Return on Equity Simple (ROE_SIMPLE)
31.32% 0.00% 38.84% 37.52% -28.64% 0.00% -1.31% 0.00% -8.22% -75.54% -12.77%
Net Operating Profit after Tax (NOPAT)
340 -271 -20 -7.70 67 -37 -19 -15 -11 -22 -2.34
NOPAT Margin
1,307.69% 0.00% -70.00% -22.00% 148.89% -232.14% -19.69% -21.90% -26.81% -57.72% -1.12%
Net Nonoperating Expense Percent (NNEP)
0.00% 2.30% 0.92% 0.40% 0.04% 0.39% 0.49% 0.00% 0.21% 0.00% 5.52%
SG&A Expenses to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 14.32% 0.00% 0.00% 6.71%
Operating Expenses to Revenue
-1,211.54% 0.00% 213.79% 145.71% -40.00% 342.60% 116.67% 141.88% 156.26% 207.83% 107.93%
Earnings before Interest and Taxes (EBIT)
341 -401 -33 -16 63 -38 -16 -28 -22 -42 -17
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
311 -429 -25 -8.00 72 -45 3.00 -26 -4.25 -32 -4.33
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.57 0.63 0.56 0.52 0.43 0.55 0.36 0.00 0.47 0.46 0.29
Price to Tangible Book Value (P/TBV)
0.89 0.91 0.80 0.74 0.62 0.61 1.23 0.00 5.20 6.58 0.00
Price to Revenue (P/Rev)
5.68 40.92 2.36 2.19 0.00 5.97 2.77 3.17 2.64 0.89 0.66
Price to Earnings (P/E)
1.81 1.50 1.44 1.38 2.80 205.07 61.61 34.54 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
55.12% 66.57% 69.47% 72.67% 35.71% 0.49% 1.62% 2.90% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.86 0.89 0.52 0.49 0.71 0.55 0.79 0.00 0.67 0.49 0.44
Enterprise Value to Revenue (EV/Rev)
28.09 220.51 3.22 3.05 0.00 6.28 22.70 0.00 5.95 1.30 1.58
Enterprise Value to EBITDA (EV/EBITDA)
9.49 0.00 1.80 1.78 0.00 0.00 235.20 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
9.46 0.00 1.96 1.93 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
8.52 0.00 1.97 1.92 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
44.33 0.00 0.72 0.68 2.31 3.74 21.76 0.00 0.00 0.00 10.69
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 1.61 0.50 0.53 0.00 0.24 0.00 0.00 0.22 0.00 3.30
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
1.99 2.59 0.37 0.38 2.39 0.00 1.95 0.00 0.12 0.00 0.11
Long-Term Debt to Equity
1.99 2.59 0.37 0.38 2.39 0.00 1.88 0.00 0.00 0.00 0.11
Financial Leverage
1.97 3.98 1.20 1.21 2.19 1.24 1.30 0.00 1.23 0.00 0.12
Leverage Ratio
8.50 8.31 8.58 8.25 8.68 5.95 6.79 0.00 7.06 1.87 4.69
Compound Leverage Factor
8.53 8.02 7.54 5.67 9.37 8.13 11.46 0.00 4.80 1.43 0.95
Debt to Total Capital
66.54% 72.12% 27.25% 27.47% 70.51% 0.00% 66.15% 0.00% 11.02% 0.00% 10.21%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 2.67% 0.00% 11.02% 0.00% 0.00%
Long-Term Debt to Total Capital
66.54% 72.12% 27.25% 27.47% 70.51% 0.00% 63.48% 0.00% 0.00% 0.00% 10.21%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
2.96% 1.54% 4.00% 4.00% 1.65% 4.89% 7.39% 0.00% 26.39% 26.50% 27.64%
Common Equity to Total Capital
30.47% 26.36% 68.77% 68.61% 27.82% 95.11% 26.46% 0.00% 62.60% 73.50% 62.15%
Debt to EBITDA
7.36 -74.20 0.93 0.99 -9.66 0.00 197.87 0.00 -2.36 0.00 -2.11
Net Debt to EBITDA
7.24 -72.95 0.34 0.36 -7.80 0.00 184.36 0.00 -2.36 0.00 0.42
Long-Term Debt to EBITDA
7.36 -74.20 0.93 0.99 -9.66 0.00 189.87 0.00 0.00 0.00 -2.11
Debt to NOPAT
6.61 -137.11 1.02 1.07 -12.76 0.00 -235.43 0.00 -2.99 0.00 -1.87
Net Debt to NOPAT
6.50 -134.79 0.38 0.39 -10.30 0.00 -219.35 0.00 -2.99 0.00 0.37
Long-Term Debt to NOPAT
6.61 -137.11 1.02 1.07 -12.76 0.00 -225.91 0.00 0.00 0.00 -1.87
Noncontrolling Interest Sharing Ratio
8.94% 0.00% 5.81% 7.74% 7.15% 5.16% 15.05% 0.00% 24.90% 26.50% 30.17%
Liquidity Ratios
- - - - - - - - - - -
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-2,951 2,378 1,391 1,220 -1,172 3,285 -3,721 1,809 4,154 -1,170 213
Operating Cash Flow to CapEx
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense
-60.22 0.00 86.92 76.27 -73.25 0.00 -186.05 483.17 761.64 -189.15 101.68
Operating Cash Flow to Interest Expense
0.98 0.00 0.00 0.00 7.00 0.00 0.00 4.22 0.00 -6.86 3.61
Operating Cash Flow Less CapEx to Interest Expense
0.98 0.00 0.00 0.00 7.00 0.00 0.00 4.22 0.00 -6.86 3.61
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.02 0.00 0.03 0.03 0.00 0.02 0.02 0.00 0.01 0.20 0.06
Fixed Asset Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
3,289 4,753 1,824 1,824 4,528 1,432 5,526 0.00 1,361 1,147 1,147
Invested Capital Turnover
0.06 0.00 0.12 0.12 0.00 0.04 0.05 0.00 0.04 0.76 0.25
Increase / (Decrease) in Invested Capital
3,291 -2,649 -1,411 -1,228 1,239 -3,321 3,702 -1,824 -4,165 1,147 -215
Enterprise Value (EV)
2,837 4,226 957 900 3,208 784 4,353 0.00 914 563 503
Market Capitalization
573 784 701 645 546 745 532 532 405 387 209
Book Value per Share
$22.42 $27.86 $27.70 $27.61 $27.90 $30.13 $30.88 $0.00 $18.43 $18.18 $15.85
Tangible Book Value per Share
$14.32 $19.25 $19.26 $19.27 $19.47 $27.23 $9.13 $0.00 $1.68 $1.27 ($6.21)
Total Capital
3,308 4,752 1,824 1,824 4,544 1,432 5,536 0.00 1,361 1,147 1,147
Total Debt
2,201 3,427 497 501 3,204 0.00 3,662 0.00 150 0.00 117
Total Long-Term Debt
2,201 3,427 497 501 3,204 0.00 3,514 0.00 0.00 0.00 117
Net Debt
2,166 3,369 183 182 2,587 -31 3,412 0.00 150 -128 -23
Capital Expenditures (CapEx)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Nonoperating Expense (NNE)
0.00 112 13 5.30 1.00 6.68 10 5.36 3.92 8.38 7.37
Net Nonoperating Obligations (NNO)
2,182 3,428 497 501 3,188 0.00 3,652 0.00 150 0.00 117
Total Depreciation and Amortization (D&A)
-30 -29 8.00 8.00 9.00 -6.76 19 1.61 18 9.74 12
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $3.83 $0.00 ($0.29) $1.44 ($0.24) ($0.63) $0.00 ($1.22) ($2.35) ($0.26)
Adjusted Weighted Average Basic Shares Outstanding
45.31M 45.72M 45.56M 45.76M 45.64M 45.64M 47.69M 0.00 47.31M 48.11M 45.30M
Adjusted Diluted Earnings per Share
$0.00 $3.92 $0.00 ($0.29) $1.41 ($0.21) ($0.63) $0.00 ($1.22) ($2.35) ($0.26)
Adjusted Weighted Average Diluted Shares Outstanding
45.85M 45.72M 45.56M 45.76M 46.81M 45.64M 47.69M 0.00 47.31M 48.11M 45.30M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
44.97M 45.29M 45.32M 45.30M 45.19M 45.20M 47.44M 0.00 46.43M 43.81M 45.01M
Normalized Net Operating Profit after Tax (NOPAT)
340 -271 -20 -7.70 67 -37 -19 -15 -11 -22 -2.34
Normalized NOPAT Margin
1,307.69% 0.00% -70.00% -22.00% 148.89% -232.14% -19.69% -21.90% -26.81% -57.72% -1.12%
Pre Tax Income Margin
1,315.38% 0.00% -100.00% -31.43% 151.11% -331.63% -28.13% -31.29% -38.30% -82.45% -1.60%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
6.96 0.00 -2.06 -1.00 3.94 0.00 -0.80 -7.42 -4.07 -6.78 -7.92
NOPAT to Interest Expense
6.94 0.00 -1.27 -0.48 4.19 0.00 -0.95 -3.88 -1.94 -3.63 -1.12
EBIT Less CapEx to Interest Expense
6.96 0.00 -2.06 -1.00 3.94 0.00 -0.80 -7.42 -4.07 -6.78 -7.92
NOPAT Less CapEx to Interest Expense
6.94 0.00 -1.27 -0.48 4.19 0.00 -0.95 -3.88 -1.94 -3.63 -1.12
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% -40.34% 0.00% 0.00% 0.00% -19.41% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Octave Specialty Group (NYSE: OSG) shows a mixed but improving near-term operating picture, though the business still carries notable balance sheet and earnings volatility. Based on the latest reported Q1 2026 results, the company generated positive operating cash flow, narrowed its quarterly net loss sharply versus the prior year, and ended the period with a solid cash position. At the same time, revenue remains highly reliant on non-interest sources, and profitability can swing materially from quarter to quarter.

  • Operating cash flow turned positive. In Q1 2026, the company generated $7.6 million in net cash from operating activities, a meaningful improvement from the negative $42.4 million reported in Q2 2025.
  • Net loss improved sharply year over year. Q1 2026 consolidated net loss was $9.7 million, better than the $30.8 million loss in Q2 2025 and the $14.5 million loss in Q1 2025.
  • Revenue growth was strong versus early 2025. Total revenue in Q1 2026 reached $208.6 million, up substantially from $39.4 million in Q1 2025 and $38.9 million in Q2 2025.
  • Liquidity improved during the quarter. Cash and due from banks rose to $93.5 million in Q1 2026 from $103.5 million in Q2 2025, while the company also reported $46.6 million of restricted cash.
  • Common equity remained substantial. Total common equity was $712.6 million at the end of Q1 2026, providing a sizeable capital base despite volatility in earnings.
  • Net interest income turned positive. Q1 2026 net interest income was $265,000, versus negative net interest income in several prior quarters.
  • Depreciation and amortization remain meaningful non-cash add-backs. These expenses continue to support reported cash flow, but they also reflect a business with sizable intangible and acquired asset balances.
  • The balance sheet is asset-heavy and complex. Goodwill, intangible assets, trading securities, and “other assets” make up a large share of total assets, which can increase valuation uncertainty.
  • Profitability remains inconsistent. The company posted a pre-tax loss of $3.3 million in Q1 2026 after a larger loss in Q2 2025, showing that earnings are still unstable quarter to quarter.
  • Non-interest expense remains elevated. Q1 2026 total non-interest expense was $225.2 million, driven heavily by current and future benefits, claims, and other operating costs.

Longer-term trend: The historical data shows that Ambac’s results have been highly volatile since 2022. The company moved from very strong earnings and cash generation in parts of 2022 and 2023 to large losses and weaker operating cash flow in 2024 and 2025, before showing some stabilization in Q1 2026. That suggests the turnaround is not yet complete, but there are signs of improvement in cash generation and quarterly earnings.

Bottom line: OSG’s latest quarter looks better than recent periods on cash flow and losses, but investors should still expect swings in performance. The key watch items are whether operating cash flow stays positive, whether expense growth can be controlled, and whether the company can sustain profitability without relying on volatile investment or non-interest income.

07/19/26 08:20 PM ETAI Generated. May Contain Errors.

Octave Specialty Group Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Octave Specialty Group's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Octave Specialty Group's net income appears to be on a downward trend, with a most recent value of -$95.80 million in 2025, falling from $986.10 million in 2015. The previous period was -$58.92 million in 2024. Check out Octave Specialty Group's forecast to explore projected trends and price targets.

Over the last 10 years, Octave Specialty Group's total revenue changed from $1.15 billion in 2015 to $148.60 million in 2025, a change of -87.0%.

Octave Specialty Group's total liabilities were at $1.14 billion at the end of 2025, a 83.4% decrease from 2024, and a 94.8% decrease since 2015.

In the past 10 years, Octave Specialty Group's cash and equivalents has ranged from $0.00 in 2016 to $623.70 million in 2017, and is currently $68.44 million as of their latest financial filing in 2025.

Over the last 10 years, Octave Specialty Group's book value per share changed from 37.42 in 2015 to 16.34 in 2025, a change of -56.3%.



Financial statements for NYSE:OSG last updated on 7/9/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners